Emrosi™ (minocycline hydrochloride extended-release capsules) is now available for the treatment of inflammatory lesions (papules and pustules) of rosacea ...

A study found that DFD-29 was more effective than both doxycycline and placebo, with a favorable risk-benefit profile for ...

Approval of the tetracycline antibiotic for this indication was supported by data from two multicenter phase III trials -- ...

Then there’s my old pal papulopustular rosacea ... and you should see results in around four treatments depending on the severity of your rosacea. There’s some recent evidence that intradermal ...

However, rosacea is a distinct condition with its own set of triggers and requires a very different approach to treatment.’ Emily West, an aesthetic nurse practitioner at Creo Clinic agrees ...

A low-dose (40 mg) modified formulation of minocycline hydrochloride (DFD-29) was better tolerated and more effective than doxycycline and placebo in patients with moderate to severe ...

announced the publication of positive results from two Phase 3 clinical trials for Emrosi™ (DFD-29), a treatment for moderate-to-severe papulopustular rosacea in adults. According to ...